The FDA's own scientists had already reviewed all of this data, and recommended against it because of a lack of evidence: "Accordingly, we propose not adding BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List" [12]
While its safe for most people to take, some drug interactions and negative reactions are possible
If you're here because you saw a peptide ad and then searched "best oral BPC-157," the skepticism is healthy
the lipidated GLP-1 molecules are bound to albumin, which is too large to be renally filtered, and are thus shielded from plasma proteases
Assuming the above, the researcher may administer DSIP via nasal spray as follows: DSIP Dosage: A total daily dose of 300mcg, with 150mcg administered in each nostril in three sprays of 50mcg each, may be applied